Yeast and zebrafish are among the lab organisms being recruited to the search for rare disease cures.
Rare diseases are not so rare. About 300 million people worldwide live with the more than 7000 individual diseases that are designated “rare” by the US government. But because each of these affect so few individuals, the usual resources and research that lead to new treatments are not available. That’s why scientists have had to get creative.
Studying organisms that may at first glance seem totally unrelated to humans is proving an important tool for understanding and finding treatments for rare disease. In a review in GENETICS, Strynatka et al. outline the ways in which laboratory model organisms are paving the way for life saving therapies, with a particular emphasis on baker’s yeast and zebrafish. Check out the review to learn more about the ingenious methods being applied, but in honor of Rare Disease Day, we’d like to highlight a couple of examples of model organism studies aiding the search for new therapies.
The yeast Saccharomyces cerevisiae has long been a powerful tool for studying the workings of the cell. As a eukaryote, S. cerevisiae shares many genes with humans and other animals, but it is a single-celled organism, so it can be more rapidly studied. Investigations in yeast demonstrated that a gene that is overexpressed in the aggressive childhood cancer rhabdomyosarcoma results in chromosomal instability. This instability made the yeast cells sensitive to drugs that are histone deacetylase inhibitors. Thanks to these insights from yeast, FDA-approved drugs in this class could one day prove useful for treating this rare cancer.
Clues to a treatment for Duchenne muscular dystrophy (DMD), an uncommon but severe disease, were uncovered using the zebrafish Danio rerio. Zebrafish can be grown quickly and boast transparent embryos that provide a remarkable window into body development. The zebrafish model of DMD harbors a premature stop codon in the homolog of the gene dmd, mimicking the human disease. This model led to the discovery that treatment with ataluren, an antibiotic, can promote read-through of this mutant stop codon. In 2014, ataluren was approved for clinical use in DMD by the European Medicines Agency.
Yeast and zebrafish have even been used in concert to identify new ways to treat rare disease. Mutations in the gene SLC25A38 cause a form of congenital sideroblastic anemia that has no effective treatment. This gene’s function remained unknown until studies in yeast showed that it transports glycine into the mitochondrion for heme synthesis. Giving mutant yeast extra glycine allowed them to produce heme at normal levels, “curing” the yeast version of the disease. However, extra glycine did not rescue heme production in zebrafish with a homologous mutation. It turns out that this disparity was due to different folate pathways in the two models. Yeast are able to synthesize folate on their own, whereas animals, like zebrafish and humans, must consume it in their diet. Giving the mutant zebrafish both glycine and folate restored heme production. These results suggested a new avenue for treatment using simple nutrients, rather than costly drugs. Further studies of the pathway in another model organism, the mouse, may reveal more about how to translate this treatment from the fish tank to clinic.
CITATION:
Science Writing and Communications Intern, Genetics Society of America.
View all posts by Marisa Wexler »Read more in
-
In Memoriam: Ellsworth Herman Grell (1932–2023), a pioneer of Drosophila genome engineering and annotation
Ellsworth (Ed) Grell blessed the Drosophila community through three enduring legacies: as a pioneer of chromosome mechanics, as a primary organizer and synthesizer of genetic knowledge in Drosophila, and as a graceful mentor to those fortunate to have known him personally. Ed grew up in rural Nebraska, completed his undergraduate studies at Iowa State, and…
-
Congratulations to the #Fungal24 Poster Award winners!
We are pleased to announce the recipients of the GSA Poster Awards for posters presented at the 32nd Fungal Genetics Conference! Undergraduate and graduate student members of GSA were eligible for the awards, and a hard-working team of judges made the determinations. Congratulations to all! Felicia Ebot Ojong, The University of Georgia My research is focused…
-
Poster presentation tips for TAGC 2024
You’ve been selected to present a poster at The Allied Genetics Conference 2024 in March—you’ve celebrated, made plans to attend, now what? This is an exciting opportunity to showcase your research and engage with fellow members of the genetics community, so you want to make sure you’re prepared. We wanted to offer you some tips…
-
Maximize your TAGC 2024 experience
A guide to all that National Harbor & DC have to offer Are you joining us for The Allied Genetics Conference 2024 in March? Make the most of your #TAGC24 experience in National Harbor! We know the science will keep you busy, but you deserve to unwind and have some fun, so we’ve curated a…
-
Early Career Leadership Spotlight: Sarah Petrosky
We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah PetroskyMultimedia SubcommitteeUniversity of Pittsburgh Research Interest I am interested in understanding adaptation that has been happening recently in populations by dissecting the ways that genes underlying an adaptation…
-
TAGC 2024 Early Career Award Winners
GSA is pleased to announce the winners of the early career awards presented at The Allied Genetics Conference 2024. These awards are specific to particular TAGC communities and recognize early career scientists’ outstanding work on their respective research organisms. The awardees will present their talks in keynote sessions at TAGC 2024. Don’t miss the opportunity…
-
Preeminent geneticists recognized with revamped GSA Awards
In 2022, GSA’s Board of Directors launched an audit to review the five major awards conferred by the Society. Today, we are thrilled to announce the recipients of the reimagined GSA Awards, including the new Genetics Society of America Early Career Medal. The scientists honored this year are recognized by their peers for their outstanding…
-
Fly Board funds outreach programs to spread the word about Drosophila research
In 2020, the Fly Board voted to use part of its reserve fund to support efforts to increase trainee participation as well as equity and diversity in the Drosophila community. An awards committee decides how the money will be spent each year, and from 2020–2022, the committee posted a very broad call for applications from…
-
New members of the GSA Board of Directors: 2024–2026
We are pleased to announce the election of four new leaders to the GSA Board of Directors: 2024 Vice President/2025 President Brenda Andrews Professor, University of Toronto It’s an honor to continue my association with the Society by serving as Vice President of the Board of Directors. I have broad knowledge of the ongoing activities…
-
Parrot plumage study aids breeders and endangered natural populations
Yellow coloration is maladaptive in the wild but prized by breeders. People have long been fascinated with birds, which exhibit one of the widest ranges of coloration among vertebrates. Parrots, in particular, have captivated humans by their ability to mimic human speech and spectacular plumage. Brightly colored feathers are used primarily to attract mates, intimidate…
-
Early Career Leadership Spotlight: Sarah Gilmour
We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah GilmourMultimedia SubcommitteeStowers Institute for Medical Research Research Interest Questions of evolution have always fascinated me. I am extremely fortunate to be starting out my research career in a…